Source link : https://www.newshealth.biz/health-news/major-pbms-inflated-drug-prices-pocketing-7-3-billion-along-the-way-ftc-says/
The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of acquisition, earning more than $7.3 billion in revenue from 2017 to 2022, according to a report issued by the Federal Trade Commission (FTC) on Tuesday. “The FTC staff’s second interim report finds that the three major pharmacy […]
Author : News Health
Publish date : 2025-01-14 21:50:21
Copyright for syndicated content belongs to the linked Source.